Microglial signalling mechanisms: Cathepsin S and Fractalkine

被引:123
作者
Clark, Anna K. [1 ]
Malcangio, Marzia [1 ]
机构
[1] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England
关键词
COLLAGEN-INDUCED ARTHRITIS; MHC CLASS-II; ACTIVATED PROTEIN-KINASE; PERIPHERAL-NERVE INJURY; LYSOSOMAL CYSTEINE PROTEASES; MYELIN BASIC-PROTEIN; T-CELL INFILTRATION; NEUROPATHIC PAIN; SPINAL-CORD; INVARIANT CHAIN;
D O I
10.1016/j.expneurol.2011.09.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A recent major conceptual advance has been the recognition of the importance of immune system-neuron interactions in the modulation of spinal pain processing. In particular, pro-inflammatory mediators secreted by immune competent cells such as microglia modulate nociceptive function in the injured CNS and following peripheral nerve damage. Chemokines play a pivotal role in mediating neuronal-microglial communication which leads to increased nociception. Here we examine the evidence that one such microglial mediator, the lysosomal cysteine protease Cathepsin S (CatS), is critical for the maintenance of neuropathic pain via cleavage of the transmembrane chemokine Fractalkine (FKN). Both CatS and FKN mediate critical physiological functions necessary for immune regulation. As key mediators of homeostatic functions it is not surprising that imbalance in these immune processes has been implicated in autoimmune disorders including Multiple Sclerosis and Rheumatoid Arthritis, both of which are associated with chronic pain. Thus, impairment of the CatS/FKN signalling pair constitutes a novel therapeutic approach for the treatment of chronic pain. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:283 / 292
页数:10
相关论文
共 109 条
[1]   Hyperalgesia in an animal model of multiple sclerosis [J].
Aicher, SA ;
Silverman, MB ;
Winkler, CW ;
Bebo, BF .
PAIN, 2004, 110 (03) :560-570
[2]   Recent developments in the immunobiology of rheumatoid arthritis [J].
Andersson, Anna K. ;
Li, Ching ;
Brennan, Fionula M. .
ARTHRITIS RESEARCH & THERAPY, 2008, 10 (02)
[3]   Phospholipases C and A2 control lysosome-mediated IL-1β secretion:: Implications for inflammatory processes [J].
Andrei, C ;
Margiocco, P ;
Poggi, A ;
Lotti, LV ;
Torrisi, MR ;
Rubartelli, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) :9745-9750
[4]   The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines [J].
Austin, Paul J. ;
Moalem-Taylor, Gila .
JOURNAL OF NEUROIMMUNOLOGY, 2010, 229 (1-2) :26-50
[5]   Characterization of chemokines and their receptors in the central nervous system: physiopathological implications [J].
Bajetto, A ;
Bonavia, R ;
Barbero, S ;
Schettini, G .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (06) :1311-1329
[6]   Role of the cysteine protease cathepsin S in neuropathic hyperalgesia [J].
Barclay, Jane ;
Clark, Anna K. ;
Ganp, Pam ;
Gentry, Clive ;
Patel, Sadhana ;
Wotherspoon, Glen ;
Buxton, Frank ;
Song, Chuanzheng ;
Ullah, Jakir ;
Winter, Janet ;
Fox, Alyson ;
Bevan, Stuart ;
Malcangio, Marzia .
PAIN, 2007, 130 (03) :225-234
[7]   Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity [J].
Baugh, Mark ;
Black, Darcey ;
Westwood, Paul ;
Kinghorn, Emma ;
McGregor, Kieran ;
Bruin, John ;
Hamilton, William ;
Dempster, Maureen ;
Claxton, Christopher ;
Cai, Jiaqiang ;
Bennett, Jonathan ;
Long, Clive ;
Mckinnon, Heather ;
Vink, Paul ;
den Hoed, Leontien ;
Gorecka, Monika ;
Vora, Kalpit ;
Grant, Ethan ;
Percival, M. David ;
Boots, A. Mieke H. ;
van Lierop, Marie-Jose .
JOURNAL OF AUTOIMMUNITY, 2011, 36 (3-4) :201-209
[8]   The origin and application of experimental autoimmune encephalomyelitis [J].
Baxter, Alan G. .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (11) :904-912
[9]   A new class of membrane-bound chemokine with a CX(3)C motif [J].
Bazan, JF ;
Bacon, KB ;
Hardiman, G ;
Wang, W ;
Soo, K ;
Rossi, D ;
Greaves, DR ;
Zlotnik, A ;
Schall, TJ .
NATURE, 1997, 385 (6617) :640-644
[10]  
Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO